My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 111

    1.

    Comparative proteome analysis of human epithelial ovarian cancer.

    Gagné JP, Ethier C, Gagné P, Mercier G, Bonicalzi ME, Mes-Masson AM, Droit A, Winstall E, Isabelle M, Poirier GG.

    Proteome Sci. 2007 Sep 24;5:16.PMID: 17892554 [PubMed - in process]Related articlesFree article

    2.

    Proteome profiling of human epithelial ovarian cancer cell line TOV-112D.

    Gagné JP, Gagné P, Hunter JM, Bonicalzi ME, Lemay JF, Kelly I, Le Page C, Provencher D, Mes-Masson AM, Droit A, Bourgais D, Poirier GG.

    Mol Cell Biochem. 2005 Jul;275(1-2):25-55.PMID: 16335783 [PubMed - indexed for MEDLINE]Related articles

    3.

    Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines.

    Presneau N, Mes-Masson AM, Ge B, Provencher D, Hudson TJ, Tonin PN.

    Oncogene. 2003 Mar 13;22(10):1568-79.PMID: 12629520 [PubMed - indexed for MEDLINE]Related articles

    4.

    Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.

    Manderson EN, Mes-Masson AM, Novak J, Lee PD, Provencher D, Hudson TJ, Tonin PN.

    Genome Res. 2002 Jan;12(1):112-21.PMID: 11779836 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysis.

    Dai L, Li C, Shedden KA, Misek DE, Lubman DM.

    Electrophoresis. 2009 Apr;30(7):1119-31.PMID: 19288585 [PubMed - indexed for MEDLINE]Related articles

    6.

    Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer.

    Gunawardana CG, Kuk C, Smith CR, Batruch I, Soosaipillai A, Diamandis EP.

    J Proteome Res. 2009 Oct;8(10):4705-13.PMID: 19663500 [PubMed - indexed for MEDLINE]Related articles

    7.

    Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.

    Murph MM, Liu W, Yu S, Lu Y, Hall H, Hennessy BT, Lahad J, Schaner M, Helland A, Kristensen G, Børresen-Dale AL, Mills GB.

    PLoS One. 2009;4(5):e5583. Epub 2009 May 15.PMID: 19440550 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes.

    Birch AH, Quinn MC, Filali-Mouhim A, Provencher DM, Mes-Masson AM, Tonin PN.

    Mol Carcinog. 2008 Jan;47(1):56-65.PMID: 17620309 [PubMed - indexed for MEDLINE]Related articles

    9.

    Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.

    Bouchal P, Roumeliotis T, Hrstka R, Nenutil R, Vojtesek B, Garbis SD.

    J Proteome Res. 2009 Jan;8(1):362-73.PMID: 19053527 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Identification of metastasis-associated proteins of ovarian cancer by proteomics]

    Zhou L, Yang XF, Wang Y, Zhang YT, Geng YP, Si LS, Wang YL.

    Zhonghua Bing Li Xue Za Zhi. 2007 Dec;36(12):814-8. Chinese. PMID: 18346353 [PubMed - indexed for MEDLINE]Related articles

    11.

    BMP-2 signaling in ovarian cancer and its association with poor prognosis.

    Le Page C, Puiffe ML, Meunier L, Zietarska M, de Ladurantaye M, Tonin PN, Provencher D, Mes-Masson AM.

    J Ovarian Res. 2009 Apr 14;2:4.PMID: 19366455 [PubMed - in process]Related articlesFree article

    12.

    Three-dimensional in vitro cell biology models of ovarian and endometrial cancer.

    Grun B, Benjamin E, Sinclair J, Timms JF, Jacobs IJ, Gayther SA, Dafou D.

    Cell Prolif. 2009 Apr;42(2):219-28. Epub 2009 Feb 16.PMID: 19222485 [PubMed - indexed for MEDLINE]Related articles

    13.

    Identification of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identification technology (MudPIT).

    Sodek KL, Evangelou AI, Ignatchenko A, Agochiya M, Brown TJ, Ringuette MJ, Jurisica I, Kislinger T.

    Mol Biosyst. 2008 Jul;4(7):762-73. Epub 2008 Apr 17.PMID: 18563251 [PubMed - indexed for MEDLINE]Related articles

    14.

    Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis.

    Barboro P, Rubagotti A, Orecchia P, Spina B, Truini M, Repaci E, Carmignani G, Romagnoli A, Introini C, Boccardo F, Carnemolla B, Balbi C.

    Cell Oncol. 2008;30(1):13-26.PMID: 18219107 [PubMed - indexed for MEDLINE]Related articles

    15.

    A Proteomic approach for protein-profiling the oncogenic ras induced transformation (H-, K-, and N-Ras) in NIH/3T3 mouse embryonic fibroblasts.

    Kim S, Lee YZ, Kim YS, Bahk YY.

    Proteomics. 2008 Aug;8(15):3082-93.PMID: 18601226 [PubMed - indexed for MEDLINE]Related articles

    16.

    The Epithelial-Mesenchymal Transition and the Estrogen-Signaling in Ovarian Cancer.

    Gallo D, Ferlini C, Scambia G.

    Curr Drug Targets. 2009 Dec 16. [Epub ahead of print]PMID: 20015012 [PubMed - as supplied by publisher]Related articles

    17.

    Overview of resistance to systemic therapy in patients with breast cancer.

    Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

    Adv Exp Med Biol. 2007;608:1-22. Review.PMID: 17993229 [PubMed - indexed for MEDLINE]Related articles

    18.

    iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy.

    Ralhan R, Desouza LV, Matta A, Chandra Tripathi S, Ghanny S, Dattagupta S, Thakar A, Chauhan SS, Siu KW.

    J Proteome Res. 2009 Jan;8(1):300-9.PMID: 19072117 [PubMed - indexed for MEDLINE]Related articles

    19.

    A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines.

    Di Michele M, Della Corte A, Cicchillitti L, Del Boccio P, Urbani A, Ferlini C, Scambia G, Donati MB, Rotilio D.

    Biochim Biophys Acta. 2009 Feb;1794(2):225-36. Epub 2008 Oct 10.PMID: 18973835 [PubMed - indexed for MEDLINE]Related articles

    20.

    Comparative proteomic analysis of paclitaxel sensitive A2780 epithelial ovarian cancer cell line and its resistant counterpart A2780TC1 by 2D-DIGE: the role of ERp57.

    Cicchillitti L, Di Michele M, Urbani A, Ferlini C, Donat MB, Scambia G, Rotilio D.

    J Proteome Res. 2009 Apr;8(4):1902-12.PMID: 19714814 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk